131 related articles for article (PubMed ID: 36008505)
1. Effect of prophylactic anti-VEGF injections on the prevention of recurrent vitreous hemorrhage in PDR patients after PRP.
Lim JW; Lee SJ; Sung JY; Kim JS; Nam KY
Sci Rep; 2022 Aug; 12(1):14484. PubMed ID: 36008505
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
Yang CS; Hung KC; Huang YM; Hsu WM
J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.
Sinawat S; Rattanapakorn T; Sanguansak T; Yospaiboon Y; Sinawat S
Eye (Lond); 2013 Dec; 27(12):1391-6. PubMed ID: 24037235
[TBL] [Abstract][Full Text] [Related]
4. Proliferative diabetic retinopathy: Role of bevacizumab in decreasing the occurrence of vitreous hemorrhage after panretinal photocoagulation.
Nehme J; Karam MA; Haber C; Hanna NG; Farhat R; Sahyoun M; Schakal A; Samaha A; Azar G; Jalkh A
J Fr Ophtalmol; 2024 Jan; 47(1):103946. PubMed ID: 37833204
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
6. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
8. Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.
Zhou AY; Zhou CJ; Yao J; Quan YL; Ren BC; Wang JM
Int J Ophthalmol; 2016; 9(12):1772-1778. PubMed ID: 28003978
[TBL] [Abstract][Full Text] [Related]
9. Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial.
Halim S; Nugawela M; Chakravarthy U; Peto T; Madhusudhan S; Lenfestey P; Hamill B; Zheng Y; Parry D; Nicholson L; Greenwood J; Sivaprasad S
JAMA Ophthalmol; 2021 May; 139(5):501-507. PubMed ID: 33704351
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
11. Panretinal Photocoagulation Plus Intravitreal Bevacizumab Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy.
Ali W; Abbasi KZ; Raza A
J Coll Physicians Surg Pak; 2018 Dec; 28(12):923-927. PubMed ID: 30501828
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF Therapy for Persistent Neovascularization after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.
Mehanna CJ; Abdul Fattah M; Haddad S; Tamim H; Ghazi N; Salti H
Ophthalmol Retina; 2019 Jun; 3(6):473-477. PubMed ID: 31174668
[TBL] [Abstract][Full Text] [Related]
15. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.
Parikh RN; Traband A; Kolomeyer AM; VanderBeek BL; Kim BJ; Maguire AM; Brucker AJ
Am J Ophthalmol; 2017 Apr; 176():194-202. PubMed ID: 28130042
[TBL] [Abstract][Full Text] [Related]
19. Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy.
Shin YW; Lee YJ; Lee BR; Cho HY
Korean J Ophthalmol; 2009 Dec; 23(4):266-72. PubMed ID: 20046686
[TBL] [Abstract][Full Text] [Related]
20. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
